Michele Malagola

3.8k total citations
107 papers, 1.5k citations indexed

About

Michele Malagola is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Michele Malagola has authored 107 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 80 papers in Hematology, 34 papers in Genetics and 24 papers in Molecular Biology. Recurrent topics in Michele Malagola's work include Acute Myeloid Leukemia Research (51 papers), Chronic Myeloid Leukemia Treatments (30 papers) and Hematopoietic Stem Cell Transplantation (25 papers). Michele Malagola is often cited by papers focused on Acute Myeloid Leukemia Research (51 papers), Chronic Myeloid Leukemia Treatments (30 papers) and Hematopoietic Stem Cell Transplantation (25 papers). Michele Malagola collaborates with scholars based in Italy, United States and France. Michele Malagola's co-authors include Michele Baccarani, Giovanni Martinelli, Pier Paolo Piccaluga, Domenico Russo, Giuseppe Visani, Simona Bernardi, Alessandro Isidori, Emanuela Ottaviani, Michela Rondoni and S Tura and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Michele Malagola

101 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michele Malagola Italy	23	1.0k	488	366	336	248	107	1.5k
Michael Pfeilstöcker Austria	22	1.9k 1.8×	594 1.2×	942 2.6×	284 0.8×	266 1.1×	83	2.3k
Prajwal Boddu United States	21	734 0.7×	373 0.8×	361 1.0×	128 0.4×	371 1.5×	51	1.2k
Uta Oelschlägel Germany	22	1.2k 1.1×	428 0.9×	392 1.1×	254 0.8×	488 2.0×	53	1.8k
Gaëlle Guillerm France	18	1.4k 1.3×	768 1.6×	527 1.4×	166 0.5×	589 2.4×	66	1.8k
Fernando Ramos Spain	21	1.2k 1.1×	524 1.1×	347 0.9×	445 1.3×	201 0.8×	68	1.5k
Josu de la Fuente United Kingdom	25	895 0.9×	619 1.3×	825 2.3×	196 0.6×	247 1.0×	86	2.1k
Denise A. Wells United States	18	1.2k 1.2×	237 0.5×	456 1.2×	204 0.6×	174 0.7×	47	1.5k
Vittorio Montefusco Italy	21	1.3k 1.2×	815 1.7×	228 0.6×	121 0.4×	656 2.6×	90	1.6k
Angela Michelutti Italy	24	701 0.7×	566 1.2×	315 0.9×	269 0.8×	662 2.7×	62	1.8k
Adriana Pleșa France	18	487 0.5×	464 1.0×	184 0.5×	136 0.4×	311 1.3×	79	1.1k

Countries citing papers authored by Michele Malagola

Since Specialization

Citations

This map shows the geographic impact of Michele Malagola's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michele Malagola with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michele Malagola more than expected).

Fields of papers citing papers by Michele Malagola

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michele Malagola. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michele Malagola. The network helps show where Michele Malagola may publish in the future.

Co-authorship network of co-authors of Michele Malagola

This figure shows the co-authorship network connecting the top 25 collaborators of Michele Malagola. A scholar is included among the top collaborators of Michele Malagola based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michele Malagola. Michele Malagola is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Farina, Mirko, Michele Malagola, Simona Bernardi, et al.. (2025). Intensive Chemotherapy Versus Venetoclax-Based Regimens in Elderly Patients with Acute Myeloid Leukemia: Is the Chemotherapy Era Ending?. Journal of Clinical Medicine. 14(8). 2759–2759. 1 indexed citations

Ferraro, Rosalba Monica, Elena Laura Mazzoldi, Mirko Farina, et al.. (2025). Different In Vitro Models of Chronic Myeloid Leukemia Show Different Characteristics: Biological Replicates Are Not Biologically Equivalent. Cell Biology International. 49(5). 570–586. 4 indexed citations

Malagola, Michele, Mirko Farina, Nicola Polverelli, et al.. (2024). Donor Lymphocyte Infusion in the Treatment of Post-Transplant Relapse of Acute Myeloid Leukemias and Myelodysplastic Syndromes Significantly Improves Overall Survival: A French–Italian Experience of 134 Patients. Cancers. 16(7). 1278–1278. 1 indexed citations

Morello, Enrico, Liana Signorini, Simona Bernardi, et al.. (2024). Nutritional Strategies To Improve VRE Control. Transplantation and Cellular Therapy. 30(5). 548.e1–548.e4. 2 indexed citations

Polverelli, Nicola, Juan Carlos Hernández‐Boluda, Nico Gagelmann, et al.. (2024). Navigating ‘grey areas’ and challenges during evaluation of transplant eligibility in specific myelofibrosis populations: a perspective on behalf of the Chronic Malignancies Working Party of the EBMT. Bone Marrow Transplantation. 60(1). 10–18. 1 indexed citations

Farina, Mirko, Luisa Lorenzi, Nicola Polverelli, et al.. (2023). High risk-myelodysplastic syndrome following CAR T-cell therapy in a patient with relapsed diffuse large B cell lymphoma: A case report and literature review. Frontiers in Oncology. 13. 1036455–1036455. 7 indexed citations

Russo, Domenico, Michele Malagola, Nicola Polverelli, et al.. (2023). Twenty years of evolution of CML therapy: how the treatment goal is moving from disease to patient. Therapeutic Advances in Hematology. 14. 1564133837–1564133837. 6 indexed citations

Polverelli, Nicola, Mirko Farina, Mariella D’Adda, et al.. (2022). How We Manage Myelofibrosis Candidates for Allogeneic Stem Cell Transplantation. Cells. 11(3). 553–553. 9 indexed citations

Bernardi, Simona, Michele Malagola, Mirko Farina, et al.. (2022). Digital PCR as a New Method for Minimal Residual Disease Monitoring and Treatment Free Remission Management in Chronic Myeloid Leukemia Patients: Is It Reliable?. SHILAP Revista de lepidopterología. 4(1). 1–11. 4 indexed citations

10.

Malagola, Michele, Alessandro Turra, Liana Signorini, et al.. (2022). Results of an Innovative Program for Surveillance, Prophylaxis, and Treatment of Infectious Complications Following Allogeneic Stem Cell Transplantation in Hematological Malignancies (BATMO Protocol). Frontiers in Oncology. 12. 874117–874117. 9 indexed citations

11.

Zizioli, Daniela, Simona Bernardi, Mirko Farina, et al.. (2021). Development of BCR-ABL1 Transgenic Zebrafish Model Reproducing Chronic Myeloid Leukemia (CML) Like-Disease and Providing a New Insight into CML Mechanisms. Cells. 10(2). 445–445. 6 indexed citations

12.

Corbellini, Silvia, Giorgio Piccinelli, Alessandro Turra, et al.. (2021). Management of Invasive Infections due to a Rare Arthroconidial Yeast, Saprochaete capitata, in Two Patients with Acute Hematological Malignancies. Vaccines. 9(11). 1289–1289. 1 indexed citations

13.

Bernardi, Simona, Mirko Farina, Federica Cattina, et al.. (2020). ETV6: A Candidate Gene for Predisposition to “Blend Pedigrees”? A Case Report from the NEXT-Famly Clinical Trial. SHILAP Revista de lepidopterología. 2020. 1–7. 6 indexed citations

14.

Cassaniti, Irene, A. Colombo, Paolo Bernasconi, et al.. (2020). Positive HCMV DNAemia in stem cell recipients undergoing letermovir prophylaxis is expression of abortive infection. American Journal of Transplantation. 21(4). 1622–1628. 44 indexed citations

15.

Bernardi, Simona, Federica Re, Kamol Dey, et al.. (2020). Chitosan-Hydrogel Polymeric Scaffold Acts as an Independent Primary Inducer of Osteogenic Differentiation in Human Mesenchymal Stromal Cells. Materials. 13(16). 3546–3546. 14 indexed citations

16.

Malagola, Michele, Nicola Polverelli, Valeria Cancelli, et al.. (2019). Biological versus Clinical Risk Factors in Acute Myeloid Leukemia: Is There a Winner?. SHILAP Revista de lepidopterología. 2019. 1–4. 1 indexed citations

17.

Schieppati, Francesca, Angela Passi, Erika Borlenghi, et al.. (2017). Molecular Monitoring of NPM1 Is a Useful Tool for Detecting Early-Stage Relapse and to Guide Pre-Emptive Treatment Approaches in Patients with NPM1-Mutated Acute Myeloid Leukemia. Blood. 130. 3931–3931. 1 indexed citations

18.

Almici, Camillo, Cristina Skert, Rosanna Verardi, et al.. (2014). Changes in Circulating Endothelial Cells Count Could Become a Valuable Tool in the Diagnostic Definition of Acute Graft-Versus-Host Disease. Transplantation. 98(7). 706–712. 25 indexed citations

19.

Filì, Carla, Michele Malagola, Matilde Y. Follo, et al.. (2013). Prospective Phase II Study on 5-Days Azacitidine for Treatment of Symptomatic and/or Erythropoietin Unresponsive Patients with Low/INT-1–Risk Myelodysplastic Syndromes. Clinical Cancer Research. 19(12). 3297–3308. 56 indexed citations

20.

Visani, Giuseppe, Silvia Buonamici, Michele Malagola, et al.. (2001). Pulsed ATRA as single therapy restores long-term remission in PML-RARα-positive acute promyelocytic leukemia patients: real time quantification of minimal residual disease. A pilot study. Leukemia. 15(11). 1696–1700. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact